基于CT尿路造影的放射组学预测透明细胞肾细胞癌的ISUP分级。

IF 3.2 3区 医学 Q2 ONCOLOGY Journal of Cancer Pub Date : 2025-01-06 eCollection Date: 2025-01-01 DOI:10.7150/jca.105173
Panpan Jiao, Bin Wang, Xinmiao Ni, Yi Lu, Rui Yang, Yunxun Liu, Jingsong Wang, Haonan Mei, Xiuheng Liu, Xiaodong Weng, Qingyuan Zheng, Zhiyuan Chen
{"title":"基于CT尿路造影的放射组学预测透明细胞肾细胞癌的ISUP分级。","authors":"Panpan Jiao, Bin Wang, Xinmiao Ni, Yi Lu, Rui Yang, Yunxun Liu, Jingsong Wang, Haonan Mei, Xiuheng Liu, Xiaodong Weng, Qingyuan Zheng, Zhiyuan Chen","doi":"10.7150/jca.105173","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> Exploring the value of predicting the WHO/ISUP grade of clear cell renal cell carcinoma (ccRCC) using computed tomography urography (CTU) images, providing valuable recommendations for the treatment of ccRCC. <b>Method:</b> CTU images from the Renmin Hospital of Wuhan University (RHWU) cohort, including 328 patients with ccRCC, were retrospectively collected. The corticomedullary (CMP) phase features of ccRCC were extracted from the CTU images using the Pyradiomics package, and key features were selected through the Least Absolute Shrinkage and Selection Operator (LASSO) regression. The 328 patients were split into training and testing sets in a 7:3 ratio. 175 patients from the The Cancer Genome Atlas (TCGA) cohort were used for the external validation set. Various models, including Logistic Regression (LR), Multilayer Perceptron (MLP), Support Vector Machine (SVM), and eXtreme Gradient Boosting (XGBoost), were employed to predict the ISUP grade. SHAP analysis was then used to visualize the performance of the best model. <b>Results:</b> A total of 1,218 features were extracted using the Pyradiomics package, with 20 features selected for model training through LASSO analysis. In the training set, the AUC for the LR model was 0.88 (95% confidence interval [CI] 0.84-0.91), for MLP it was 0.89 (95% CI 0.86-0.93), for SVM it was 0.86 (95% CI 0.83-0.90), and for XGBoost it was 0.96 (95% CI 0.92-0.99). In the testing set, the AUC for LR was 0.79 (95% CI 0.73-0.85), for MLP it was 0.78 (95% CI 0.72-0.83), for SVM it was 0.78 (95% CI 0.73-0.82), and for XGBoost it was 0.80 (95% CI 0.75-0.85). In the validation set, the AUC for LR was 0.74 (95% CI 0.68-0.79), for MLP it was 0.68 (95% CI 0.63-0.73), for SVM it was 0.67 (95% CI 0.64-0.71), and for XGBoost it was 0.78 (95% CI 0.74-0.83). XGBoost demonstrated superior performance, with a sensitivity of 0.99 (95% CI 0.96-1.00) in the training set, 0.92 (95% CI 0.88-0.97) in the testing set and 0.91 (95% CI 0.86,0.95) in validation set. SHAP analysis revealed that the wavelet-LHL_glcm_Idn and wavelet-LHL_glrlm_LongRunEmphasis features played pivotal roles in the classification task. <b>Conclusion:</b> In this study, we employ an artificial intelligence model to conduct non-invasive ISUP grade prediction on preoperative CTU images of ccRCC, thereby aiding clinical decision-making. Additionally, we uncover that the radiomics features extracted from the CMP phase of CTU images hold promise as potential biomarkers for grading ccRCC.</p>","PeriodicalId":15183,"journal":{"name":"Journal of Cancer","volume":"16 4","pages":"1118-1126"},"PeriodicalIF":3.2000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11786028/pdf/","citationCount":"0","resultStr":"{\"title\":\"CT Urography-Based Radiomics to Predict ISUP Grading of Clear Cell Renal Cell Carcinoma.\",\"authors\":\"Panpan Jiao, Bin Wang, Xinmiao Ni, Yi Lu, Rui Yang, Yunxun Liu, Jingsong Wang, Haonan Mei, Xiuheng Liu, Xiaodong Weng, Qingyuan Zheng, Zhiyuan Chen\",\"doi\":\"10.7150/jca.105173\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Purpose:</b> Exploring the value of predicting the WHO/ISUP grade of clear cell renal cell carcinoma (ccRCC) using computed tomography urography (CTU) images, providing valuable recommendations for the treatment of ccRCC. <b>Method:</b> CTU images from the Renmin Hospital of Wuhan University (RHWU) cohort, including 328 patients with ccRCC, were retrospectively collected. The corticomedullary (CMP) phase features of ccRCC were extracted from the CTU images using the Pyradiomics package, and key features were selected through the Least Absolute Shrinkage and Selection Operator (LASSO) regression. The 328 patients were split into training and testing sets in a 7:3 ratio. 175 patients from the The Cancer Genome Atlas (TCGA) cohort were used for the external validation set. Various models, including Logistic Regression (LR), Multilayer Perceptron (MLP), Support Vector Machine (SVM), and eXtreme Gradient Boosting (XGBoost), were employed to predict the ISUP grade. SHAP analysis was then used to visualize the performance of the best model. <b>Results:</b> A total of 1,218 features were extracted using the Pyradiomics package, with 20 features selected for model training through LASSO analysis. In the training set, the AUC for the LR model was 0.88 (95% confidence interval [CI] 0.84-0.91), for MLP it was 0.89 (95% CI 0.86-0.93), for SVM it was 0.86 (95% CI 0.83-0.90), and for XGBoost it was 0.96 (95% CI 0.92-0.99). In the testing set, the AUC for LR was 0.79 (95% CI 0.73-0.85), for MLP it was 0.78 (95% CI 0.72-0.83), for SVM it was 0.78 (95% CI 0.73-0.82), and for XGBoost it was 0.80 (95% CI 0.75-0.85). In the validation set, the AUC for LR was 0.74 (95% CI 0.68-0.79), for MLP it was 0.68 (95% CI 0.63-0.73), for SVM it was 0.67 (95% CI 0.64-0.71), and for XGBoost it was 0.78 (95% CI 0.74-0.83). XGBoost demonstrated superior performance, with a sensitivity of 0.99 (95% CI 0.96-1.00) in the training set, 0.92 (95% CI 0.88-0.97) in the testing set and 0.91 (95% CI 0.86,0.95) in validation set. SHAP analysis revealed that the wavelet-LHL_glcm_Idn and wavelet-LHL_glrlm_LongRunEmphasis features played pivotal roles in the classification task. <b>Conclusion:</b> In this study, we employ an artificial intelligence model to conduct non-invasive ISUP grade prediction on preoperative CTU images of ccRCC, thereby aiding clinical decision-making. Additionally, we uncover that the radiomics features extracted from the CMP phase of CTU images hold promise as potential biomarkers for grading ccRCC.</p>\",\"PeriodicalId\":15183,\"journal\":{\"name\":\"Journal of Cancer\",\"volume\":\"16 4\",\"pages\":\"1118-1126\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-01-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11786028/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7150/jca.105173\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/jca.105173","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨ct尿路成像(CTU)对透明细胞肾细胞癌(ccRCC) WHO/ISUP分级的预测价值,为ccRCC的治疗提供有价值的建议。方法:回顾性收集武汉大学人民医院(RHWU) 328例ccRCC患者的CTU图像。利用Pyradiomics软件包从CTU图像中提取ccRCC的皮质髓质(CMP)相特征,并通过最小绝对收缩和选择算子(LASSO)回归选择关键特征。328名患者按7:3的比例分为训练组和测试组。来自癌症基因组图谱(TCGA)队列的175例患者被用于外部验证集。各种模型,包括逻辑回归(LR),多层感知器(MLP),支持向量机(SVM)和极端梯度增强(XGBoost),被用来预测ISUP等级。然后使用SHAP分析来可视化最佳模型的性能。结果:Pyradiomics包共提取了1218个特征,通过LASSO分析选择了20个特征进行模型训练。在训练集中,LR模型的AUC为0.88(95%置信区间[CI] 0.84-0.91), MLP模型的AUC为0.89 (95% CI 0.86-0.93), SVM模型的AUC为0.86 (95% CI 0.83-0.90), XGBoost模型的AUC为0.96 (95% CI 0.92-0.99)。在测试集中,LR的AUC为0.79 (95% CI 0.73-0.85), MLP的AUC为0.78 (95% CI 0.72-0.83), SVM的AUC为0.78 (95% CI 0.73-0.82), XGBoost的AUC为0.80 (95% CI 0.75-0.85)。在验证集中,LR的AUC为0.74 (95% CI 0.68-0.79), MLP的AUC为0.68 (95% CI 0.63-0.73), SVM的AUC为0.67 (95% CI 0.64-0.71), XGBoost的AUC为0.78 (95% CI 0.74-0.83)。XGBoost表现出优异的性能,在训练集中的灵敏度为0.99 (95% CI 0.96-1.00),在测试集中的灵敏度为0.92 (95% CI 0.88-0.97),在验证集中的灵敏度为0.91 (95% CI 0.86,0.95)。SHAP分析表明,wavelet-LHL_glcm_Idn和wavelet-LHL_glrlm_LongRunEmphasis特征在分类任务中发挥了关键作用。结论:本研究采用人工智能模型对ccRCC术前CTU图像进行无创ISUP分级预测,帮助临床决策。此外,我们发现从CTU图像的CMP阶段提取的放射组学特征有望作为ccRCC分级的潜在生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
CT Urography-Based Radiomics to Predict ISUP Grading of Clear Cell Renal Cell Carcinoma.

Purpose: Exploring the value of predicting the WHO/ISUP grade of clear cell renal cell carcinoma (ccRCC) using computed tomography urography (CTU) images, providing valuable recommendations for the treatment of ccRCC. Method: CTU images from the Renmin Hospital of Wuhan University (RHWU) cohort, including 328 patients with ccRCC, were retrospectively collected. The corticomedullary (CMP) phase features of ccRCC were extracted from the CTU images using the Pyradiomics package, and key features were selected through the Least Absolute Shrinkage and Selection Operator (LASSO) regression. The 328 patients were split into training and testing sets in a 7:3 ratio. 175 patients from the The Cancer Genome Atlas (TCGA) cohort were used for the external validation set. Various models, including Logistic Regression (LR), Multilayer Perceptron (MLP), Support Vector Machine (SVM), and eXtreme Gradient Boosting (XGBoost), were employed to predict the ISUP grade. SHAP analysis was then used to visualize the performance of the best model. Results: A total of 1,218 features were extracted using the Pyradiomics package, with 20 features selected for model training through LASSO analysis. In the training set, the AUC for the LR model was 0.88 (95% confidence interval [CI] 0.84-0.91), for MLP it was 0.89 (95% CI 0.86-0.93), for SVM it was 0.86 (95% CI 0.83-0.90), and for XGBoost it was 0.96 (95% CI 0.92-0.99). In the testing set, the AUC for LR was 0.79 (95% CI 0.73-0.85), for MLP it was 0.78 (95% CI 0.72-0.83), for SVM it was 0.78 (95% CI 0.73-0.82), and for XGBoost it was 0.80 (95% CI 0.75-0.85). In the validation set, the AUC for LR was 0.74 (95% CI 0.68-0.79), for MLP it was 0.68 (95% CI 0.63-0.73), for SVM it was 0.67 (95% CI 0.64-0.71), and for XGBoost it was 0.78 (95% CI 0.74-0.83). XGBoost demonstrated superior performance, with a sensitivity of 0.99 (95% CI 0.96-1.00) in the training set, 0.92 (95% CI 0.88-0.97) in the testing set and 0.91 (95% CI 0.86,0.95) in validation set. SHAP analysis revealed that the wavelet-LHL_glcm_Idn and wavelet-LHL_glrlm_LongRunEmphasis features played pivotal roles in the classification task. Conclusion: In this study, we employ an artificial intelligence model to conduct non-invasive ISUP grade prediction on preoperative CTU images of ccRCC, thereby aiding clinical decision-making. Additionally, we uncover that the radiomics features extracted from the CMP phase of CTU images hold promise as potential biomarkers for grading ccRCC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Cancer
Journal of Cancer ONCOLOGY-
CiteScore
8.10
自引率
2.60%
发文量
333
审稿时长
12 weeks
期刊介绍: Journal of Cancer is an open access, peer-reviewed journal with broad scope covering all areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. The Journal is supported by an international editorial board consisting of a distinguished team of cancer researchers. Journal of Cancer aims at rapid publication of high quality results in cancer research while maintaining rigorous peer-review process.
期刊最新文献
A CRM-Integrated ypT Staging System Improves Prognostic Stratification Following Neoadjuvant Therapy in Rectal Cancer. Integrative Multi-Omics and Single-Cell Profiling Identify Chitinase Domain Containing Protein 1 (CHID1) as a Prognostic Biomarker in Glioblastoma. Recurrence of Adult Granulosa Cell Tumors: The Factors Affecting Secondary Recurrence and Survival After Recurrence. Integrative analysis of lysosome-dependent cell death related molecular subtypes and prognosis prediction in papillary thyroid carcinoma. FAM188B promotes progression of hepatocellular carcinoma by regulating YAP/TAZ via interaction with USP10.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1